CHORDC1 and urinary bladder carcinoma: Furthermore, Kaplan-Meier survival analysis revealed that the higher expression of VAMP5, TIGIT, LCK, CHORDC1, CD27, and CACYBP was correlated with better outcomes in bladder cancer patients treated with immunotherapy (Fig. 2B).